What question did this study set out to answer?

To review the mechanisms of the IL-6/JAK2/STAT3 signaling pathway in tumorigenesis and evaluate its potential as a therapeutic target across multiple human cancers.

December 16, 2022SHILAP Revista de lepidopterologíaOpen Access

The role of IL-6/JAK2/STAT3 signaling pathway in cancers

View Full Paper

Ask AI

Bookmark

Authors

BHBei HuangZhejiang A & F University XLXiaoling LangSichuan University XLXihong LiCentral South University

Discussion

Member takes

Overview

Review reveals the central role of IL-6/JAK2/STAT3 signaling across diverse solid malignancies, highlighting novel opportunities for targeted cancer therapeutics.

Key Points

To review the mechanisms of the IL-6/JAK2/STAT3 signaling pathway in tumorigenesis and evaluate its potential as a therapeutic target across multiple human cancers.
Synthesized molecular literature on IL-6 activation of the JAK2/STAT3 signaling cascade and downstream effector molecules.
Evaluated pathway contributions to tumor growth across liver, breast, colorectal, gastric, lung, pancreatic, and ovarian cancers.
Aberrant activation of the IL-6/JAK2/STAT3 pathway drives tumor cell proliferation, survival, and differentiation.
Sustained pathway signaling promotes the formation and maintenance of a pro-tumorigenic inflammatory microenvironment across diverse cancer types.

Cite This Study

Huang et al. (2022) studied this question.

synapsesocial.com/papers/69dfeea035659245ec6152f8 https://doi.org/10.3389/fonc.2022.1023177

View Full Paper

Ask AI

Bookmark

December 16, 2022SHILAP Revista de lepidopterologíaOpen Access

The role of IL-6/JAK2/STAT3 signaling pathway in cancers

View Full Paper

Ask AI

Bookmark

Authors

BHBei HuangZhejiang A & F University XLXiaoling LangSichuan University XLXihong LiCentral South University

Discussion

Member takes

Overview

Review reveals the central role of IL-6/JAK2/STAT3 signaling across diverse solid malignancies, highlighting novel opportunities for targeted cancer therapeutics.

Key Points

To review the mechanisms of the IL-6/JAK2/STAT3 signaling pathway in tumorigenesis and evaluate its potential as a therapeutic target across multiple human cancers.
Synthesized molecular literature on IL-6 activation of the JAK2/STAT3 signaling cascade and downstream effector molecules.
Evaluated pathway contributions to tumor growth across liver, breast, colorectal, gastric, lung, pancreatic, and ovarian cancers.
Aberrant activation of the IL-6/JAK2/STAT3 pathway drives tumor cell proliferation, survival, and differentiation.
Sustained pathway signaling promotes the formation and maintenance of a pro-tumorigenic inflammatory microenvironment across diverse cancer types.

Cite This Study

Huang et al. (2022) studied this question.

synapsesocial.com/papers/69dfeea035659245ec6152f8 https://doi.org/10.3389/fonc.2022.1023177

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark